Cart
sales@molnova.com
AG-120 (racemic)
CAS No. 1448346-63-1
AG-120 (racemic) ( —— )
Catalog No. M23614 CAS No. 1448346-63-1
AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 59 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 127 | In Stock |
|
| 25MG | 252 | In Stock |
|
| 50MG | 371 | In Stock |
|
| 100MG | 552 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG-120 (racemic)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
-
DescriptionAG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorIDH1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1448346-63-1
-
Formula Weight583.0
-
Molecular FormulaC28H22ClF3N6O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/ml (171.54 mM); Ethanol:100 mg/ml (171.54 mM)
-
SMILESO=C1CC[C@@H](C(N(C(C(NC2CC(F)(F)C2)=O)C3=CC=CC=C3Cl)C4=CC(F)=CN=C4)=O)N1C5=NC=CC(C#N)=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M Cecilia Caino, Dario C Altieri. Clin Cancer Res. 2016 Feb 1;22(3):540-5.
molnova catalog
related products
-
Isovaleramide
Isovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
-
L-Allylglycine
L-Allylglycine is a potent inhibitor of the synthetic enzyme for GABA, glutamic acid decarboxylase.
-
IDH889
IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt).
